Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4141 AL 4155

Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson's disease

Gong X, Tan S, Yang Y, Yu Y, Yao X, Liu H.

Drug Discov Today. 2025 Sep;30(9):104446. doi: 10.1016/j.drudis.2025.104446. Epub 2025 Aug 13.

Phytochemicals and brain health: The effects of curcumin, isoflavonoids, and ouabain

Cantanzaro AB, Orellana AM.

Prog Brain Res. 2025;295:135-188. doi: 10.1016/bs.pbr.2025.05.004. Epub 2025 May 23.

Hormesis and brain diseases

Lim VJT, Tabassum NI, Orian JM, Arumugam TV, Weng EF.

Prog Brain Res. 2025;295:229-258. doi: 10.1016/bs.pbr.2025.05.003. Epub 2025 May 28.

Intermittent fasting and ketone bodies

Oliveira Dos Santos GR, de Souza Lima TA, Gallus M, Kawamoto EM.

Prog Brain Res. 2025;295:39-82. doi: 10.1016/bs.pbr.2025.05.002. Epub 2025 May 21.

Can regulators have a role in facilitating the development of new medicines for Parkinson's disease?

Rosa MM, Balkowiec-Iskra E.

J Parkinsons Dis. 2025 Aug 6:1877718X251360584. doi: 10.1177/1877718X251360584. Online ahead of print.

Risk factors and predictors for Lewy body dementia: a systematic review

Ratnavel A, Dino FR, Jiang C, Azmy S, Wyman-Chick KA, Bayram E.

NPJ Dement. 2025;1(1):20. doi: 10.1038/s44400-025-00022-2. Epub 2025 Aug 4.

Artificial intelligence in neurodegenerative diseases research: a bibliometric analysis since 2000

Zhang Y, Yu L, Lv Y, Yang T, Guo Q.

Front Neurol. 2025 Jul 16;16:1607924. doi: 10.3389/fneur.2025.1607924. eCollection 2025.

Functional, Nutraceutical and Health Endorsing Perspectives of Saffron

Tufail T, Ain HBU, Ikram A, Arshad MT, Abdullahi MA.

Food Sci Nutr. 2025 Aug 6;13(8):e70721. doi: 10.1002/fsn3.70721. eCollection 2025 Aug.

Multi-Center 3D CNN for Parkinson's disease diagnosis and prognosis using clinical and T1-weighted MRI data

Basaia S, Sarasso E, Sciancalepore F, Balestrino R, Musicco S, Pisano S, Stankovic I, Tomic A, Micco R, Tessitore A, Salvi M, Meiburger KM, Kostic VS, Molinari F, Agosta F, Filippi M.

Neuroimage Clin. 2025;48:103859. doi: 10.1016/j.nicl.2025.103859. Epub 2025 Aug 5.

Strategies to rescue mitochondria in Parkinson's disease: The significance of mitochondrial transfer

Liang J, Su Z, Su G, Rasheed M, Tang S, Sunniya H, Maazouzi M, Cui Y, Wang J, Wang X, Yang J, Ding M, Li Z, Deng Y.

Ageing Res Rev. 2025 Dec;112:102856. doi: 10.1016/j.arr.2025.102856. Epub 2025 Aug 5.

Imaging Proinflammatory Microglia in Parkinson Disease Using [(11)C]SMW139 PET: A Multicenter Study

Rikken RM, van de Giessen E, Brumberg J, Aarnio R, Joling M, Forsberg Morén A, Kerstens V, Moein MM, Nag S, Halldin C, Fazio P, Roos DS, Berendse HW, Kassiou M, Wahlroos S, Haaparanta-Solin M, Oikonen V, Schuit RC, Boellaard R, Windhorst AD, Jacobs AH, Lammertsma AA, Rinne JO, Varrone A, Golla SSV.

J Nucl Med. 2025 Oct 1;66(10):1646-1651. doi: 10.2967/jnumed.125.269671.

Leveraging open cheminformatics tools for non-targeted metabolomics analysis of C. elegans: a workflow comparison and application to strains related to xenobiotic metabolism and neurodegeneration

Frigerio G, Lai Y, Schymanski EL, Miller GW.

Anal Bioanal Chem. 2025 Nov;417(27):6089-6106. doi: 10.1007/s00216-025-06048-y. Epub 2025 Aug 8.

Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders

Detyniecki K, Strzelczyk A, Roebling R, Laloyaux C, Chanteux H, Cloyd JC.

CNS Drugs. 2025 Nov;39(11):1109-1138. doi: 10.1007/s40263-025-01213-4. Epub 2025 Aug 7.

Neuromelanin-induced cellular stress and neurotoxicity in the pathogenesis of Parkinson's disease

Jakaria M, Cannon JR.

Apoptosis. 2025 Dec;30(11-12):2481-2494. doi: 10.1007/s10495-025-02156-3. Epub 2025 Aug 7.

Recent Advances in AI for Parkinson's Disease Diagnosis: A Scoping Review

Cao W, Liu J, Liu S.

Stud Health Technol Inform. 2025 Aug 7;329:1956-1957. doi: 10.3233/SHTI251297.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias